Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Director Declaration

31st May 2024 12:00

RNS Number : 6721Q
RTW Biotech Opportunities Ltd
31 May 2024
 

LEI: 549300Q7EXQQH6KF7Z84

31 May 2024

RTW Biotech Opportunities Ltd (the "Company")

Director Declaration

In accordance with LR 9.6.14, the Company announces that Paul Le Page, a non-executive director of the Company, will join the board of Sequoia Economic Infrastructure Income Fund Limited, as a non-executive director with effect from 7 June 2024.

For Further Information:

 

RTW Investments, LP

+44 (0)20 7959 6361

[email protected]

Woody Stileman, Managing Director

Krisha McCune, Director, Investor Relations

 

 

 

 

About RTW Biotech Opportunities Ltd:

RTW Biotech Opportunities Ltd (LSE: RTW & RTWG) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Biotech Opportunities Ltd invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives. RTW Biotech Opportunities Ltd is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.

Visit the website at www.rtwfunds.com/rtw-biotech-opportunities-ltd for more information

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNBGGDURGXDGSB

Related Shares:

Rtw Biotech
FTSE 100 Latest
Value8,275.66
Change0.00